Cell line · CVCL_6934
OCM-1
Cancer cell line, Homo sapiens. Amelanotic melanoma. Cellosaurus records it as contaminated. 17 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. OCM-1. Cell lines, record CVCL_6934. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_6934
On this page
Cell line
As Cellosaurus gives it.
- Name
- OCM-1
- Accession
- CVCL_6934
- RRID
- RRID:CVCL_6934
- Synonyms
- OCM1, Ocm1, Ocular Choroidal Melanoma-1
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 33Y
- Category
- Cancer cell line
- Diseases
- Amelanotic melanoma (NCIt C3802)
- Derived from
- Right buttock, hypodermis (metastatic)
- Parent
- M14 (CVCL_1395)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Contaminated | Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with uveal melanoma. |
Source Cellosaurus
Papers17
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Inositol (1,4,5)-trisphosphate 5-phosphatase promotes survival of uveal melanoma by regulating oncogenic G protein-driven calcium oscillations. | J Biol Chem | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Circ_0053943 complexed with IGF2BP3 drives uveal melanoma progression via regulating N6-methyladenosine modification of Epidermal growth factor receptor. | Oncol Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH-Peptide Conjugates. | Int J Mol Sci | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic Analyses. | Mol Cell Proteomics | 2023 | Its Methods give the RRID and name the line | PubMed | |
| TERT accelerates BRAF mutant-induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis. | Sci Adv | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma. | J Biol Chem | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Targeting primary and metastatic uveal melanoma with a G protein inhibitor. | J Biol Chem | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line. | Int J Cancer | 2018 | Cellosaurus cites it | PubMed | |
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity. | Eur J Cancer | 2013 | Cellosaurus cites it | PubMed | |
| Genetic and molecular characterization of uveal melanoma cell lines. | Pigment Cell Melanoma Res | 2012 | Cellosaurus cites it | PubMed |
1 to 10 of 17
See all 17 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | M14 | CVCL_1395 | Cell lines | |
| Derived from it | OCM-1A | CVCL_6935 | Has a recorded problem | Cell lines |
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_6934
GET https://conductscience.org/api/cell-lines/v1/CVCL_6934/problems